437 related articles for article (PubMed ID: 6255005)
21. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
Riggs BL
Endocrinol Jpn; 1979 Jun; 26(Suppl):31-41. PubMed ID: 467347
[TBL] [Abstract][Full Text] [Related]
22. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.
Caniggia A; Lorè F; di Cairano G; Nuti R
J Steroid Biochem; 1987; 27(4-6):815-24. PubMed ID: 3320561
[TBL] [Abstract][Full Text] [Related]
23. A patient with pseudohypoparathyroidism with increased serum calcium and 1 alpha, 25-dihydroxyvitamin D after exogenous parathyroid hormone administration.
Lawoyin S; Norman DA; Zerwekh JE; Breslau NA; Pak CY
J Clin Endocrinol Metab; 1979 Nov; 49(5):783-6. PubMed ID: 489718
[TBL] [Abstract][Full Text] [Related]
24. Regulation of vitamin D metabolism in normal human pregnancy.
Reddy GS; Norman AW; Willis DM; Goltzman D; Guyda H; Solomon S; Philips DR; Bishop JE; Mayer E
J Clin Endocrinol Metab; 1983 Feb; 56(2):363-70. PubMed ID: 6600459
[TBL] [Abstract][Full Text] [Related]
25. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.
Civitelli R; Agnusdei D; Nardi P; Zacchei F; Avioli LV; Gennari C
Calcif Tissue Int; 1988 Feb; 42(2):77-86. PubMed ID: 3127028
[TBL] [Abstract][Full Text] [Related]
26. Effects of estrogen on response to edetic acid infusion in postmenopausal osteoporotic women.
Cosman F; Nieves J; Horton J; Shen V; Lindsay R
J Clin Endocrinol Metab; 1994 Apr; 78(4):939-43. PubMed ID: 8157725
[TBL] [Abstract][Full Text] [Related]
27. Serum vitamin D metabolites in younger and elderly postmenopausal women.
Christiansen C; Rødbro P
Calcif Tissue Int; 1984 Jan; 36(1):19-24. PubMed ID: 6423232
[TBL] [Abstract][Full Text] [Related]
28. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations.
Hillman LS; Slatopolsky E; Haddad JG
J Clin Endocrinol Metab; 1978 Nov; 47(5):1073-7. PubMed ID: 318093
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
32. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women.
Gennari C; Agnusdei D; Nardi P; Civitelli R
J Clin Endocrinol Metab; 1990 Nov; 71(5):1288-93. PubMed ID: 2229286
[TBL] [Abstract][Full Text] [Related]
33. Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women.
Shapses SA; Kendler DL; Robson R; Hansen KE; Sherrell RM; Field MP; Woolf E; Berd Y; Mantz AM; Santora AC
J Bone Miner Res; 2011 Aug; 26(8):1836-44. PubMed ID: 21448918
[TBL] [Abstract][Full Text] [Related]
34. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
35. Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women.
Krall EA; Sahyoun N; Tannenbaum S; Dallal GE; Dawson-Hughes B
N Engl J Med; 1989 Dec; 321(26):1777-83. PubMed ID: 2594036
[TBL] [Abstract][Full Text] [Related]
36. The effect of different vitamin D treatments on serum vitamin D levels in early postmenopausal women.
Riis B; Christiansen C; Rodbro P
Acta Vitaminol Enzymol; 1984; 6(2):77-82. PubMed ID: 6093487
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
Chesney RW; Hamstra A; Rose P; DeLuca HF
Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
[TBL] [Abstract][Full Text] [Related]
38. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
Riggs BL; Nelson KI
J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
[TBL] [Abstract][Full Text] [Related]
39. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
[TBL] [Abstract][Full Text] [Related]
40. Effects of conjugated estrogen on the calcitriol response to parathyroid hormone in postmenopausal women.
Marcus R; Villa ML; Cheema M; Cheema C; Newhall K; Holloway L
J Clin Endocrinol Metab; 1992 Feb; 74(2):413-8. PubMed ID: 1309837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
